Company profile: Open Health
1.1 - Company Overview
Company description
- Provider of medical communications, omni, HEOR, and market access services, including market access strategy; health economic modeling and meta-analysis; patient engagement; patient-centered outcomes; real-world evidence and data analytics; medical affairs consultancy and strategy; publications planning and delivery; scientific communications; and learning and development.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Open Health
ADVI Health
HQ: United States
Website
- Description: Provider of boutique health care advisory services, including market access and pricing strategy; federal and state policy monitoring and modeling; strategic analytics, value and economics; coding and reimbursement for Medicare, Medicaid, VA-DOD, and private payers; and data-driven financial services due diligence to quantify risks, opportunities, and trends.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ADVI Health company profile →
Arcus Medica
HQ: United States
Website
- Description: Provider of medical and scientific communications consulting services with full-service capabilities and expertise in oncology, hematology, transplant, and rare diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arcus Medica company profile →
BioVectra
HQ: Canada
Website
- Description: Provider of contract development and manufacturing services for intermediates and active pharmaceutical ingredients, with over 40 years' experience serving global pharmaceutical and biotechnology clients. Capabilities span synthetic organic chemistry, microbial fermentation for biologics (e.g., recombinant insulin), synthetic small molecules, highly potent APIs, bioreagents, and pDNA/mRNA production.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioVectra company profile →
Lucy Scientific
HQ: Canada
Website
- Description: Provider of research, development, and manufacturing of controlled psychotropic drugs, offering targeted formulations, single molecule fractions, crude extracts, raw materials, and white- and private-label products to support mental research and the creation of psychotropic and psychedelic therapeutics across organic, synthetic, and biosynthetic categories.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lucy Scientific company profile →
Omiics
HQ: Denmark
Website
- Description: Provider of RNA sequencing solutions and comprehensive NGS services tailored to research needs, including consultation, RNA extraction from tissues and biofluids, sample and library preparation (rRNA depletion, UMI tagging for low-input), sequencing via Illumina, DNBseq, and Oxford Nanopore with long-read, on-site capabilities, plus bioinformatics/data analysis and result interpretation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Omiics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Open Health
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Open Health
2.2 - Growth funds investing in similar companies to Open Health
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Open Health
4.2 - Public trading comparable groups for Open Health
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →